Curriculum Vitae of: Bruce Lawrence Saltz, M.D.
Undergraduate Education:
(1974 - 1978)





 Duke University, Durham, North Carolina
Degree:  Bachelor of Science
Honors:
Magna Cum Laude

Dean’s List
Class Honors
Major: Psychology

(1978 - 1982)
University of Florida, College of Medicine, Gainesville, Florida
Degree:  Doctor of Medicine

Honors: Graduation with Honors for Research
Graduate Medical Education:
(1982 - 1983)
 The George Washington University Medical Center, Washington, D.C.
Internship:  Department of Internal Medicine
Graduate Medical Education:
(1983 - 1986) The Mount Sinai Medical Center, New York, New York

Residency:           Department of Psychiatry
Chief Residency:  Department of Psychiatry, Geriatric Psychiatry Unit
Graduate Medical Education:
(1986 - 1988) Hillside Hospital, Division of The Long Island Jewish Medical Center (LIJMC)
Psychopharmacology Research Fellowship - Department of Psychiatry
Professional Experience:
(1988 - 1989) Medical Director, Senior Citizen’s Treatment Program

Hillside Hospital, Division of The Long Island Jewish Medical Center
Professional Experience:
(1989 - 1992) Research Psychiatrist

Hillside Hospital, Division of The Long Island Jewish Medical Center
Staff Psychiatrist - Geropsychiatry Division-Hillside Hospital - LIJMC
Assistant Professor of Psychiatry - Albert Einstein College of Medicine
Co-Investigator - NIMH  Prospective Study of Tardive Dyskinesia in the Elderly (1986 - 1992)
Investigator in Sandoz Clinical Trials for Clozaril Use in Treatment Refractory Schizophrenia
Professional Experience:
(1992 - Present) Private Practitioner, Boca Raton/Delray Beach/Pompano Beach/Fort Lauderdale - Florida
President/Owner - Mental Health Advocates, Inc., Boca Raton, Florida 
(1998 - 2005)
 Principal Investigator - National Institute of Aging/NIH SBIR Project
Phases I and II - Educational Material for Geriatric Psychopharmacology
(2000-2011) Principal Investigator, Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE), and Schizophrenia Trials Network (STN) sponsored by NIMH and UNC
(2008 – Present) ---Voluntary Associate Professor of Psychiatry at The University of Miami Miller School of Medicine.
---Affiliate Associate Professor of Psychiatry and Biomedical Science at Florida Atlantic University.
Certifications: Diplomate, National Board of Medical Examiners, 1983
Diplomate, American Board of Psychiatry and Neurology, 1987
Diplomate, American Board of Psychiatry and Neurology, with added qualification in Geriatric Psychiatry, 1991, 2001, 2011
Distinguished Fellow American Psychiatric Association, 2017
Professional Society Memberships:
American Psychiatric Association - Distinguished LIfe Fellow
American Association for Geriatric Psychiatry (1990 - Present)
American Society of Clinical Psychopharmacology (2008-Present)  - Fellow
Other Professional Activities:
Long Island Jewish Medical Center Human Subjects Review Committee
         (Institutional Review Board) (1988 - 1992)
Huntington’s Disease Society of America - Southern New York Chapter
          Medical Advisory Board (1989 - 1991)
LIJMC-Quality Assurance Subcommittee (1991 - 1992)
Imperial Point Partial Hospitalization Program, Utilization Rev. Mgmt. (1992 - 1994)
Consultant, Novartis Pharmaceuticals (1998 - 2000)(P.I. 2005-2007, Clinical Trial Bipolar Disorder)
Consultant, Eli Lilly Pharmaceutical Company (1998-1999; 2006-2008)(P.I. 2004, Clinical Trial )
Consultant, Astra Zeneca Pharmaceutical Company (2000)(P.I., 2004-Present, Clinical Trial)
Consultant, Janssen Pharmaceutica ( 2000-2007) Rater Training on Movement Disorders (A.I.M.S., Barnes Akathisia, Simpson Angus Extrapyramidal Side Effects Scale, ESRS).
Consultant, Cephalon Pharmaceuticals (2008-Present  P.I. Clinical Trial)
National Institutes of Health, Institute on Aging, SBIR-Special Grant Rev.Committee (1998 - 2002)
Research Consultant, Henderson Mental Health Center, Ft. Lauderdale, Florida 33312 (1999-2006)
Consumer’s Rsch Council of America Guide to America’s Top Psychiatrists (2008)
Member Board of Directors – SE Florida Association for Psychoanalytic Psychology (2009-2013)
Consultant Palm Beach Treasure Coast 2-1-1, Crisis and Referral Service
Member Council on Geriatric Psychiatry, APA  (2012-2016)
Reviewer NCDEU / ASCP – Scientific Program Committee (2010-2017)

Publications:
A.  Original Communications in Reviewed Journals
  1. Novogrodsky A, Suthanthiran M, Saltz B, Newman D, Rubin L, Stenzel K: Generations lymphocyte growth factor by treatment of human cells with neuraminidase and galactose oxidase.  J Experimental Medicine 151:755-760, 1980.
  2. Lieberman JA, Johns CA, Kane JM, Rai K, Pisciotta A, Saltz B, Howard A: Clozapine induced agranulocytosis: Non-cross reactivity with other psychotropic drugs.  J Clin Psychiatry 49:271-2, 1988.
  3. Lieberman J, Lesser M, Johns C, Pollack S, Saltz B, Kane: Pharmacologic studies of tardive dyskinesia. J Clin Psychopharmacology, Vol 8 (4 Suppl): 57S-63S, 1988.
  4. Lieberman JA, Saltz BL, Johns CA, Pollack S, Kane J: Clozapine effects on tardive dyskinesia. Psychopharmacology Bulletin, 57-62, 1989.
  5. Lieberman JA, Saltz BL, Johns CA, Pollack S, Borenstein M, Kane J. The effects of Clozapine on tardive dyskinesia.  British Journal of Psychiatry, 158:503-510, 1991.
  6. Saltz BL, Woerner MG, Kane JM, Lieberman JA, Alvir JMJ, Bergmann KJ, Blank K, Koblenzer J, Kahaner K.  Prospective study of tardive dyskinesia incidence in the elderly. Journal of American Medical Association, 266:2402-2406, 1991.
  7. Saltz BL.  Tardive dyskinesia in the elderly patient. Hospital Practice, Vol. 27 (4), 1992.
  8. Umbricht DSG, Saltz B, Pollack S, Woerner M, Kane JM, Lieberman JA. Polydipsia and Tardive Dyskinesia in Chronic Psychiatric Patients - Related Disorders? American Journal Psychiatry, 150:1536 - 1538, 1993.
  9. Woerner MG, Saltz BL, Kane JM, Lieberman JA, Alvir JMJ.  Diabetes and Development Tardive Dyskinesia.  American Journal of Psychiatry, 150: 966 - 968, 1993.
  10. Saltz, Bruce L. Schizophrenia in the Nursing Home. Nursing Home Medicine, 3:248 - 253, 1995.
  11. Woerner MG, Alvir JMJ, Kane JM, Saltz BL, Lieberman JA. Neuroleptic Treatment of Elderly Patients.  Psychopharmacology Bulletin, 31:333 - 337, 1995.
  12. Woerner MG, Alvir JMJ, Saltz BL, Lieberman JA, and Kane JM. Prospective Study and Risk Factors of Tardive Dyskinesia.  The American Journal of Psychiatry, 155:1521 - 1528, 1998.
  13. Saltz BL, Woerner MG, Robinson DG, Kane JM.  ecognizing and Managing Antipsychotic Drug Side Effects.  Postgraduate Medicine, 107: 169 - 178, 1999.
  14. Saltz BL, Robinson DG, Woerner MG.  Recognizing and Managing Antipsychotic Drug Side Effects in the Elderly.  Journal of Clinical Psychiatry, Primary Care Companion, 2003 (5).
  15. Lieberman JA, Berry S, Miller D, Saltz BL, Stahl SM. Safety Considerations in the use of Atypical Antipsychotics.  Journal of Clinical Psychiatry, Primary Care Companion Reports, October 2003, Vol3(3).
  16. Miller DD, McEvoy JP, Davis S, Caroff SN, Saltz BL, Chakos MH, Swartz M, Keefe R, Rosenheck R, Stroup S, Lieberman JA: Clinical Correlates of Tardive
  17. Dyskinesia in Schizophrenia: Baseline Data from CATIE Schizophrenia Trial. Schizophrenia Research, 2005.
  18. Lieberman JA, Stroup TS, McEvoy JP et al: Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia.  New England Journal of Medicine, 2005; 353:  1209-23.
  19. Miller DD, Caroff  SN, Davis SM, Rosenheck RA, McEvoy JP, Saltz BL et al.  Extrapyramidal Side Effects of Antipsychotics in a Randomised Trial.  The British Journal of Psychiatry, 2008; 193:  279-288.
  20. Caroff SN, Davis VG, Miller DD, Davis SM, Rosenheck RA, McEvoy JE, Saltz BL, et al., for the CATIE Investigators. Treatment outcomes of patients with tardive dyskinesia and chronic schizophrenia. Journal of Clinical Psychiatry, 2010.
B.  Chapters in Books
  1. Saltz BL and Lieberman JA: Spontaneous and drug induced disorders of movement in the elderly In Young R. And Joseph AB (eds): Disorders of Movement in Psychiatry and Neurology.  Blackwell Scientific Publications, Inc., Boston, Massachusetts, 1992, pp. 155-163.
  2. Leipzig R. And Saltz BL: Adverse reactions to psychotropics in geriatric patients.  In Lieberman JA, Kane JM (eds): Adverse Effects of Psychotropic Drugs.  Guilford Press, New York 1992, 447-469.
  3. Saltz BL, Kane JM, Woerner MG, Lieberman JA, Alvir, JMJ:  Aging and Tardive Dyskinesia.  In Neuroleptic-Induced Movement Disorders.  Eds., Yassa R, Nair NPV, and Jeste DV, 1997.
C.  Abstracts, Posters, and Presentations
  1. Saltz BL, Kane JM, Woerner MG, Lieberman JL, Alvir JMJ, May 1988: Prospective Study Tardive Dyskinesia in the Elderly: American Psychiatric Association, New Research Section, Montreal.
  2. Saltz BL, Kane JM, Woerner MG, Lieberman JL, Alvir JMJ, June 1988: Prospective Study Tardive Dyskinesia in the Elderly: New Clinical Drug Evaluation Unit, Key Biscayne, Florida.
  3. Lemus CZ, Lieberman JA, Johns CA, Pollack S, Saltz BL, May 1989: Neuroendocrine Effects Clozapine in Schizophrenia: American Psychiatric Association, New Research Section, San Francisco, California.
  4. Masiar S and Saltz BL, Workshop on the Recent Advances in the Treatment of Schizophrenia.  The Annual Community Conference for Families of the Mentally ill, sponsored by Hillside Hospital AMI/P.A.T.H.  October 1989, Long Island Jewish Medical Center, Glen Oaks, New York.
  5. Saltz BL.  Tardive dyskinesia and aging.  Geriatric Psychiatry Seminar at Beth Israel hospital, New York, New York, March 1990.
  6. Saltz BL, Kane JM, Woerner MG, Lieberman JA, Alvir JMJ, Bergmann K.  May 1990: Prospective Study of Tardive Dyskinesia in the Elderly: Society for Biological Psychiatry, New York, New York.
  7. Saltz B.  Tardive Dyskinesia.  Symposium on Psychotropic Drug Use in the Elderly.  May, 19 The Parker Jewish Geriatric Institute, New Hyde Park, New York.
  8. Saltz B.  Tardive dyskinesia in the Elderly, June 1990, Continuing Medical Education - Grand Rounds: Pilgrim Psychiatric Center, West Brentwood, New York.
  9. Saltz B and Insall S.  Workshop on the Recent Advances in the Treatment of Schizophrenia.  Fourth Annual Community Conference for Families of the Mentally ill, Sponsored by Hillside Hospital and AMI/ P.A.T.H.  October 1990, Long Island Jewish Medical Center, New Hyde Park, New York.
  10. Antipsychotic Drug Use in the Elderly.  Continuing Medical Education Conference on Antipsychotic Drug Use in the Nursing Home: A One-Day OBRA >87 Update, Sponsored by GPS Pharmacy Services, September 1990, Philadelphia, Pennsylvania: September 26, 1990, Pittsburgh, Pennsylvania; October 3, 1990, Harrisburg, Pennsylvania.
  11. Saltz BL, Woerner MG, Lieberman JA, Alvir JMJ, and Kane JM.  Drug Induced Parkinsonism in Elderly Individuals Undergoing neuroleptic Therapy for the First Time.  April 1990: International Congress on Schizophrenia Research, Tucson, Arizona.
  12. Saltz BL, Lieberman JA, Pollack S, Pestreich L, Westrich L.  Clinical Correlates of Plasma HVA During neuroleptic Withdrawal, April 1990: International Congress on Schizophrenia Research, Tucson, Arizona.
  13. Saltz BL, Leipzig RM, Roose SP, Pomara N, Ewing J.  Symposium on Aging and Adverse Drug Reactions.  American Psychiatric Association, May 15, 1991: New Orleans, Louisiana.
  14. Saltz BL.  Nassau County Medical Center-Grand Rounds: New Developments in T.D., Jan.10, 1992.
  15. Woerner MG, Alvir JMJ, Kane JM, Lieberman JA, Saltz B.  Neuroleptic Treatment of Elderly Patients.  New Clinical Drug Evaluation Unit, Marco island, Florida (June 1, 1994).
  16. Saltz BL.  Dementia and Depression in Older Adults.  Florida State Guardianship Association, 1994 Annual Meeting.  Westin Hotel, Fort Lauderdale, Florida.
  17. Saltz BL, Wessel J, Boyer E, Milstein R.  Mock Capacity Hearing - Demonstration: Elder Law The Law and Practicalities of Guardianship, Stetson University College of Law, West Palm Beach, Florida, October 26, 1995.
  18. Saltz BL, Moderator, Baum S, and Kalt U Seminar: Tips for Managing Stress in the New Millennium: Boca Raton, Florida, December 1999.
  19. Saltz BL, Robinson DG, Woerner MG, Borenstein MB, Kane JM. Recognizing and Managing Antipsychotic Drug Side Effects in the Elderly. March 13, 2000, American Association of Geriatric Psychiatry, Miami, Florida.
  20. Saltz BL, Woerner MG, Robinson, DG, Borenstein MB, Kane John K. Recognition and Management of Psychosis, Agitation, and Drug Induced Side Effects in the Elderly, American Association of Geriatric Psychiatry, San Juan, Puerto Rico, March 12, 2006.
  21. Saltz, BL. Drug Induced Movement Disorders in the Elderly: Workshop on Teaching Teachers to Employ Video on Recognizing Dyskinesia, Dystonia, Akathisia, and Parkinsonism. American Psychiatric Association, May 2014 New York
CV  Version – November 2017